These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 28491862

  • 21. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A, Nilsen T, Sunde K, Norell M, Hansson LO, Larsson A.
    Clin Lab; 2017 May 01; 63(5):907-913. PubMed ID: 28627817
    [Abstract] [Full Text] [Related]

  • 22. Fecal Calprotectin: Diagnostic Accuracy of the Immunochromatographic CalFast Assay in a Pediatric Population.
    Radillo O, Pascolo L, Martelossi S, Dal Bo S, Ventura A.
    J Clin Lab Anal; 2016 Sep 01; 30(5):500-5. PubMed ID: 26879689
    [Abstract] [Full Text] [Related]

  • 23. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V, Malmstrøm GH, Skar V, Røseth A, Moum B.
    Scand J Gastroenterol; 2016 Sep 01; 51(5):548-55. PubMed ID: 26634305
    [Abstract] [Full Text] [Related]

  • 24. Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
    Amcoff K, Stridsberg M, Lampinen M, Magnuson A, Carlson M, Halfvarson J.
    Scand J Gastroenterol; 2017 Mar 01; 52(3):344-350. PubMed ID: 27881032
    [Abstract] [Full Text] [Related]

  • 25. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J.
    Korean J Gastroenterol; 2016 May 25; 67(5):233-7. PubMed ID: 27206433
    [Abstract] [Full Text] [Related]

  • 26. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E, Manz M, Rothen C, Rossi L, Beglinger C, Lehmann FS.
    Clin Chim Acta; 2013 Feb 01; 416():41-7. PubMed ID: 23178549
    [Abstract] [Full Text] [Related]

  • 27. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE.
    J Pediatr Gastroenterol Nutr; 2001 Jul 01; 33(1):14-22. PubMed ID: 11479402
    [Abstract] [Full Text] [Related]

  • 28. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.
    Inflamm Bowel Dis; 2008 May 01; 14(5):669-73. PubMed ID: 18240279
    [Abstract] [Full Text] [Related]

  • 29. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A, D'Incà R, Scapellato ML, De Bastiani R, Caccaro R, Mescoli C, Moz S, Bozzato D, Zambon CF, Lorenzon G, Rugge M, Plebani M, Basso D.
    Clin Chem Lab Med; 2018 Oct 25; 56(11):1926-1935. PubMed ID: 29729144
    [Abstract] [Full Text] [Related]

  • 30. Validation of Two Calprotectin Rapid Tests in Daily Routine.
    Schulz C, Wex T, Arnim UV, Malfertheiner P.
    Clin Lab; 2016 Jul 01; 62(7):1249-1254. PubMed ID: 28164652
    [Abstract] [Full Text] [Related]

  • 31. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
    Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, Festen EAM, Wijmenga C, Jonkers DMAE, Dijkstra G, Fu J, Zhernakova A, Imhann F, Weersma RK.
    Gut Microbes; 2021 Jul 01; 13(1):1943288. PubMed ID: 34313538
    [Abstract] [Full Text] [Related]

  • 32. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
    Gucenmez OA, Kume T, Makay B, Babayigit O, Arslan N, Unsal E.
    Int J Rheum Dis; 2018 Oct 01; 21(10):1844-1848. PubMed ID: 30345692
    [Abstract] [Full Text] [Related]

  • 33. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Oct 01; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 34. Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations.
    Laserna-Mendieta EJ, Lucendo AJ.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1295-1307. PubMed ID: 30785706
    [Abstract] [Full Text] [Related]

  • 35. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct 27; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 36. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study.
    Prell C, Nagel D, Freudenberg F, Schwarzer A, Koletzko S.
    BMJ Open; 2014 May 02; 4(5):e004558. PubMed ID: 24793248
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q, Schatt P, Grimmelprez A, Gohy P, Deltour D, Collard G, Vankerkhoven P.
    Clin Biochem; 2016 Feb 02; 49(3):268-73. PubMed ID: 26506117
    [Abstract] [Full Text] [Related]

  • 38. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct 02; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

  • 39. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2005 Apr 02; 40(4):450-5. PubMed ID: 15795593
    [Abstract] [Full Text] [Related]

  • 40. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
    Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, Castro M.
    Inflamm Bowel Dis; 2008 Sep 02; 14(9):1229-35. PubMed ID: 18398894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.